S2Medical AB (publ) (S2M.ST)

SEK 0.01

(4.55%)

Net Income Summary of S2Medical AB (publ)

  • S2Medical AB (publ)'s latest annual net income in 2023 was -22.7 Million SEK , up 27.28% from previous year.
  • S2Medical AB (publ)'s latest quarterly net income in 2024 Q2 was 6.93 Million SEK , up 762.44% from previous quarter.
  • S2Medical AB (publ) reported an annual net income of -31.22 Million SEK in 2022, down -53.64% from previous year.
  • S2Medical AB (publ) reported an annual net income of -20.32 Million SEK in 2021, down -34.75% from previous year.
  • S2Medical AB (publ) reported a quarterly net income of 6.93 Million SEK for 2024 Q2, up 762.44% from previous quarter.
  • S2Medical AB (publ) reported a quarterly net income of -4.98 Million SEK for 2023 Q1, up 34.86% from previous quarter.

Annual Net Income Chart of S2Medical AB (publ) (2023 - 2015)

Historical Annual Net Income of S2Medical AB (publ) (2023 - 2015)

Year Net Income Net Income Growth
2023 -22.7 Million SEK 27.28%
2022 -31.22 Million SEK -53.64%
2021 -20.32 Million SEK -34.75%
2020 -15.08 Million SEK 18.64%
2019 -18.53 Million SEK -72.75%
2018 -10.73 Million SEK -99.57%
2017 -5.37 Million SEK -349.96%
2016 -1.19 Million SEK -42839.63%
2015 2796.00 SEK 0.0%

Peer Net Income Comparison of S2Medical AB (publ)

Name Net Income Net Income Difference
AddLife AB (publ) 190 Million SEK 111.951%
Biotage AB (publ) 246 Million SEK 109.231%
Bonesupport Holding AB (publ) 245.02 Million SEK 109.268%
Doxa AB (publ) 291.9 Million SEK 107.779%
Elekta AB (publ) 1.3 Billion SEK 101.744%
iZafe Group AB (publ) -32.17 Million SEK 29.425%
Ortivus AB (publ) -18.24 Million SEK -24.459%
Ortivus AB (publ) -18.24 Million SEK -24.459%
Q-linea AB (publ) -229.36 Million SEK 90.1%
Synsam AB (publ) 311 Million SEK 107.301%